Showing 2,671 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C treatment

Is There Any Good Reason Left to Delay Hepatitis C Treatment?

Editor's pick
Poz
17 April 2015
Hepatitis C symptoms & diagnosis

Cepheid announces European approval of Xpert HCV Viral Load

Editor's pick
Cepheid press release
16 April 2015
Hepatitis B

Arrowhead initiates phase 2b trial for potential HBV drug

Editor's pick
Healio Hepatology
14 April 2015
Hepatitis C treatment

Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie

Editor's pick
The Street
9 April 2015
New & experimental hepatitis C treatment

Grazoprevir/Elbasvir, Merck’s Investigational Chronic Hepatitis C Therapy, Granted FDA Breakthrough Therapy Designations

Editor's pick
Merck press release
9 April 2015
New & experimental hepatitis C treatment

At 50 Cents a Pill, Allergy Drug Could Best $1000 Sovaldi, Harvoni

Editor's pick
Healthline
9 April 2015
Hepatitis C treatment

Abstracts Have Been Posted: International Liver Congress™ 2015 of the European Association for the Study of the Liver (EASL)

Editor's pick
HCV New Drugs Research
9 April 2015
Hepatitis C treatment

WHO Issues Guideline For Manufacturers Of Generic Hepatitis C Medicine

Editor's pick
Intellectual Property Watch
8 April 2015
Hepatitis B

Global hepatitis B epidemic treatable at cost of just $36 per patient per year

News
8 April 2015
Hepatitis & HIV

End-stage liver disease is a concern for people with HIV and hepatitis B or C co-infection

News
7 April 2015
Harm reduction

Alert: Serbia is losing harm reduction

Editor's pick
Eurasian Harm Reduction Network
2 April 2015
Diabetes

Cannabis use reduces risk of insulin resistance in people with HIV/HCV co-infection

News
2 April 2015
Hepatitis B

Oral hepatitis B vaccine could become a reality

Editor's pick
Medical Xpress
1 April 2015
Hepatitis C treatment

Cipla announces the launch of generic drug Sofosbuvir in India under the brand name ‘Hepcvir`

Editor's pick
Cipla press release
31 March 2015
Hepatitis C treatment

Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Sovaldi® (sofosbuvir) for the Treatment of Genotype 2 Chronic Hepatitis C

Editor's pick
Gilead press release
31 March 2015
Hepatitis C transmission & prevention

HCV sexual transmission linked to anal sex, drug use, lower CD4 count

News
31 March 2015
Hepatitis C transmission & prevention

World first trials for hepatitis C wonder drug in Sydney's maximum security jails

Editor's pick
Sydney Morning Herald
30 March 2015
Access to healthcare

KEI Europe asks Romanian government to issue compulsory licences on hepatitis C medicines

Editor's pick
Knowledge Ecology International
23 March 2015
Access to healthcare

Indian generic companies should reject Gilead’s controversial hepatitis C ‘Anti-Diversion’ programme

Editor's pick
MSF
19 March 2015
Access to healthcare

Gilead to require proof of citizenship to buy Sovaldi in poor countries

Editor's pick
Fierce Pharma
19 March 2015
Hepatitis C treatment

Bristol-Myers Squibb Co. Is Back in the Hepatitis C Race

Editor's pick
Motley Fool
18 March 2015
Hepatitis C treatment

Hepatitis C Drugs Will 'Strain Budgets': Study

Editor's pick
WebMD
17 March 2015
Hepatitis C treatment

Gilead's hepatitis C drugs largely cost-effective in US - study

Editor's pick
Reuters
17 March 2015
Hepatitis C treatment

Sustained virological response represents a long-term cure for people with hepatitis C treated with sofosbuvir

News
17 March 2015